Advertisement

Home / India / India offered 7.5 million doses of Moderna vaccine, no consensus on indemnity clause

India offered 7.5 million doses of Moderna vaccine, no consensus on indemnity clause

It is unclear when jabs provided under COVAX scheme will arrive in country
Moderna's Covid-19 vaccine was granted emergency use authorisation by India's drug regulator last month.
Moderna's Covid-19 vaccine was granted emergency use authorisation by India's drug regulator last month.
File picture

Our Bureau, PTI   |   New Delhi   |   Published 20.07.21, 10:53 AM

India has been offered 7.5 million doses of Moderna's Covid-19 vaccine through the COVAX global vaccine sharing programme, but it is not clear when the jabs will arrive in the country as a consensus on the indemnity clause is yet to be reached, sources said.

The government last week said that it is working actively with vaccine manufacturer Moderna to see how its vaccine can be made available in the country.

Advertisement

Moderna's Covid-19 vaccine was granted emergency use authorisation by India's drug regulator last month.

"India has been offered 7.5 million doses of Moderna's Covid-19 vaccine through the COVAX global vaccine sharing programme," the sources said.

However, there is no clarity so far when the shots would be available in India as "the talks are still on and a consensus on the indemnity issue is yet to be reached," they said.

On the availability of Moderna vaccine in the country, NITI Aayog member (Health) Dr V K Paul had recently said the government is working actively with Moderna to see how its vaccine can be imported and made available in the country.

"...to and fro (talks) are going on over the contractual specifics. Discussions have not yet concluded. We are making efforts as to it happens at the earliest. We are now expecting to hear from them anytime. Currently, they have to respond to some of the points we have made and we will take it forward," he had said on Friday.

According to the sources, the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent it to the US drug manufacturer for their perusal.
 



Advertisement
Advertisement
Advertisement
 
 
 
Copyright © 2020 The Telegraph. All rights reserved.